$TENX
Tenax Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is TENX up today? It is at $2.03 (+16.01%), and our scanner flagged it 261 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TENX spikes, and full due diligence on TENX — key stats, earnings, dilution and insider activity. Free.
Get free $TENX alerts the moment volume spikes
Our scanner flagged $TENX 261 times in the last 30 days. Create a free account to track $TENX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.03
- Change today
- +16.01%
- Previous close
- $1.75
- 52-week range
- $1.31 – $19.40
- Market cap
- $65M
- Institutional own.
- 86.60%
- Total held
- 94.5%
- Tradeable float
- 2.1M 5% of shares · after 8% insiders + 87% institutions
- Short interest
- 2.6M ▲ +25% vs prior · as of 2026-07-31
- Days to cover
- 1.9d
- Avg daily volume
- 1.2M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 2.2x
- 15mthin
- 1.6x
- 1hthin
- 1.7x
- 1D
- 2.4x
Get free TENX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $TENX up today?
TENX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on TENX today, peaking at 58.5x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Analyst data via Nasdaq. Not investment advice.
Insiders
10 open-market buys0 buys, 0 sells last 3 months (13/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Giordano Christopher Thomas Officer | Other | 9K 0.02% of company | added 100% | 11K | $31K at $3.55 | Jul 13, 26 |
Staab Thomas R Ii Officer | Acquired (grant/award) | +10K 0.03% of company | n/a | 10K | n/a | May 11, 26 |
Rich Stuart Officer | Bought (open market) | +3K | added 90% | 5K | $26K at $10.22 | Dec 9, 25 |
Rich Stuart Officer | Bought (open market) | +3K | added 51% | 7K | $25K at $10.10 | Dec 8, 25 |
Rich Stuart Officer | Bought (open market) | +3K | added 100% | 5K | $23K at $9.20 | Dec 4, 25 |
Rich Stuart Officer | Bought (open market) | +2K | added 100% | 3K | $14K at $9.08 | Dec 3, 25 |
Rich Stuart Officer | Bought (open market) | +1K | added 100% | 1K | $9K at $9.01 | Dec 2, 25 |
Giordano Christopher Thomas Officer | Bought (open market) | +538 | added 26% | 3K | $4K at $7.59 | Nov 20, 25 |
Giordano Christopher Thomas Officer | Bought (open market) | +455 | added 28% | 2K | $3K at $7.51 | Nov 19, 25 |
Almenoff June Sherie Director | Bought (open market) | +2K | added 100% | 2K | $14K at $7.52 | Nov 18, 25 |
Giordano Christopher Thomas Officer | Bought (open market) | +2K | n/a | 2K | $12K at $7.75 | Nov 18, 25 |
Almenoff June Sherie Director | Bought (open market) | +93 | n/a | 93 | $665 at $7.15 | Nov 17, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $TENX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $300.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$TENX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$TENX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to TENX
Comparable names in pharmaceutical preparations, closest in size first.
TENX stock FAQ
Why is $TENX up today?
TENX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on TENX today, peaking at 58.5x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
What is the TENX stock price today?
TENX last traded at $2.03, up 16.01% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live TENX alerts?
The TENX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TENX 261 times in the last 30 days.
What exchange is TENX on?
TENX (Tenax Therapeutics, Inc.) trades on XNAS, with a market cap of about $65M in the PHARMACEUTICAL PREPARATIONS sector.
Is TENX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TENX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.